SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-005561
Filing Date
2024-01-18
Accepted
2024-01-18 20:00:08
Documents
1
Period of Report
2024-01-16

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 6378
  Complete submission text file 0000950170-24-005561.txt   7940
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 212-994-8250
MiNK Therapeutics, Inc. (Issuer) CIK: 0001840229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address
van Dijk Marcus Antonius (Reporting) CIK: 0001881659 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40908 | Film No.: 24543427